| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous..
>Volltext.. |
| 942.34 Mio. EUR |
| 896.53 Mio. EUR |
| - |
| -114.17 Mio. EUR |
| -111.52 Mio. EUR |
| -0.94 EUR |
| 13.48 Mio. EUR |
| 58.85 Mio. EUR |
| -87.87 Mio. EUR |
| 1.41 |
| - |
| -19.73% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 18.02.26 |